- Home
- LINK vs ABOS Comparison
LINK vs ABOS Comparison
Compare LINK & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LINK
- ABOS
- Stock Information
- Founded
- LINK 1984
- ABOS 1996
- Country
- LINK United States
- ABOS United States
- Employees
- LINK N/A
- ABOS N/A
- Industry
- LINK Industrial Machinery/Components
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- LINK Technology
- ABOS Health Care
- Exchange
- LINK Nasdaq
- ABOS Nasdaq
- Market Cap
- LINK 60.0M
- ABOS 66.6M
- IPO Year
- LINK N/A
- ABOS 2021
- Fundamental
- Price
- LINK $6.10
- ABOS $1.08
- Analyst Decision
- LINK
- ABOS Strong Buy
- Analyst Count
- LINK 0
- ABOS 3
- Target Price
- LINK N/A
- ABOS $7.33
- AVG Volume (30 Days)
- LINK 4.9K
- ABOS 250.0K
- Earning Date
- LINK 05-12-2025
- ABOS 05-13-2025
- Dividend Yield
- LINK N/A
- ABOS N/A
- EPS Growth
- LINK N/A
- ABOS N/A
- EPS
- LINK N/A
- ABOS N/A
- Revenue
- LINK $11,679,000.00
- ABOS N/A
- Revenue This Year
- LINK $2.19
- ABOS N/A
- Revenue Next Year
- LINK $12.68
- ABOS N/A
- P/E Ratio
- LINK N/A
- ABOS N/A
- Revenue Growth
- LINK N/A
- ABOS N/A
- 52 Week Low
- LINK $3.25
- ABOS $0.86
- 52 Week High
- LINK $10.90
- ABOS $3.92
- Technical
- Relative Strength Index (RSI)
- LINK 48.48
- ABOS 49.38
- Support Level
- LINK $5.79
- ABOS $1.00
- Resistance Level
- LINK $6.98
- ABOS $1.16
- Average True Range (ATR)
- LINK 0.34
- ABOS 0.11
- MACD
- LINK 0.04
- ABOS 0.02
- Stochastic Oscillator
- LINK 28.46
- ABOS 75.00
About LINK Interlink Electronics Inc.
Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.